Evidence map›Paper›PMID 33626953›Full record

ArticleInternational journal of immunopathology and pharmacology

Expression of cPLA

Ewa Pniewska-Dawidczyk, Izabela Kupryś-Lipińska, Gabriela Turek, Dorota Kacprzak, Joanna Wieczfinska, Paulina Kleniewska, Piotr Kuna, Rafal Pawliczak

Open access · goldAbstract readComparative Study
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of immunopathology and pharmacology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Ewa Pniewska-DawidczykDepartment of Immunopathology, Medical University of Lodz, Lodz, Poland.
Izabela Kupryś-LipińskaDepartment of Internal Medicine, Asthma and Allergy, Medical University of Lodz, Lodz, Poland.
Gabriela TurekDepartment of Immunopathology, Medical University of Lodz, Lodz, Poland.
Dorota KacprzakDepartment of Immunopathology, Medical University of Lodz, Lodz, Poland.
Joanna WieczfinskaDepartment of Immunopathology, Medical University of Lodz, Lodz, Poland.ORCID https://orcid.org/0000-0002-8830-1507
Paulina KleniewskaDepartment of Immunopathology, Medical University of Lodz, Lodz, Poland.
Piotr KunaDepartment of Internal Medicine, Asthma and Allergy, Medical University of Lodz, Lodz, Poland.
Rafal PawliczakDepartment of Immunopathology, Medical University of Lodz, Lodz, Poland.ORCID https://orcid.org/0000-0001-6784-453X
Medical University of Lodz · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic inflammation in asthmatics is initiated/exacerbated by many environmental factors, such as bacterial lipopolysaccharide and allergens. Phospholipase A

Indexed as

AsthmaAdultAllergensAntigens, DermatophagoidesE1A-Associated p300 ProteinFemaleGroup IV Phospholipases A2Histone Deacetylase 1Histone Deacetylase 2HumansLeukocytes, MononuclearLipopolysaccharidesMaleMiddle AgedRNA, MessengerSeverity of Illness IndexAllergensAntigens, DermatophagoidesE1A-Associated p300 ProteinEP300 protein, humanGroup IV Phospholipases A2HDAC1 protein, humanHDAC2 protein, humanHistone Deacetylase 1Histone Deacetylase 2LipopolysaccharidesPLA2G4C protein, humanRNA, MessengerallergensasthmacPLA2HATHDAC

Identifiers

PMID33626953
PMCPMC7925951
OpenAlexW3132249375

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.